Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots, flowers, seeds, and leaves have been utilized to alleviate pain, inflammation, anxiety, and gastrointestinal disorders like nausea, vomiting, diarrhoea, and inflamma...
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2023-10, Vol.24 (19), p.14677 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 19 |
| container_start_page | 14677 |
| container_title | International journal of molecular sciences |
| container_volume | 24 |
| creator | Thapa, Dinesh Warne, Leon N Falasca, Marco |
| description | Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots, flowers, seeds, and leaves have been utilized to alleviate pain, inflammation, anxiety, and gastrointestinal disorders like nausea, vomiting, diarrhoea, and inflammatory bowel diseases (IBDs). It has occupied a significant space in ethnomedicines across cultures and religions. Despite multi-dimensional uses, the global prohibition of cannabis by the USA through the introduction of the Marijuana Tax Act in 1937 led to prejudice about the perceived risks of cannabis, overshadowing its medicinal potential. Nevertheless, the discovery of tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, and the endocannabinoid system renewed scientific interest in understanding the role of cannabis in modulating different conditions, including gastrointestinal disorders. Preparations combining cannabidiol and THC have shown promise in mitigating gut symptoms through anti-inflammatory and motility-enhancing effects. This review revisits the ethnomedicinal use of cannabis in gastrointestinal diseases and emphasizes the need for further research to determine optimal dosages, formulations, and safety profiles of cannabis-based medicines. It also underscores the future potential of cannabinoid-based therapies by leveraging the role of the expanded endocannabinoid system, an endocannabinoidome, in the modulation of gastrointestinal ailments. |
| doi_str_mv | 10.3390/ijms241914677 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10572150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A771808598</galeid><sourcerecordid>A771808598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-3ef9b8bb52973eddde7ee09ad91823bfcc623748d1a2cd3eb7904de899c34da3</originalsourceid><addsrcrecordid>eNptks9u1DAQxi0EoqVw5G6JC5cU_0ni-IRWu7QgVdBDOVuOPdn1yrEXOynaGw_BE_ZJ6qUVsAj5MJb9m2_m0wxCryk551ySd247ZlZTSetWiCfolNaMVYS04ulf9xP0IuctIYyzRj5HJ1x0vKaMnSJ_vdFp1CZuXJ5i2uM44KUOQfcu468Z7n78XODP8B1fx5xd77yb9tgFfDFPcwK8SvMar-AWfNyNECY8xIQvdZ5SdGGCPLmgPV65DDpDfomeDdpnePUYz9DNxYeb5cfq6svlp-XiqjJ1S6aKwyD7ru8bJgUHay0IACK1lbRjvB-MaRkXdWepZsZy6IUktYVOSsNrq_kZev8gu5v7EawpfSXt1S65Uae9itqp45_gNmodbxUljWC0IUXh7aNCit_mYkONLhvwXgeIc1asE4KXqrwr6Jt_0G2cU3H9i2oFL003f6i19qBcGGIpbA6iaiEE7UjXyIPW-X-ociyMzsQAgyvvRwnVQ4JJZTwJht8mKVGH9VBH68HvAUUMrpE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876739185</pqid></control><display><type>article</type><title>Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Thapa, Dinesh ; Warne, Leon N ; Falasca, Marco</creator><creatorcontrib>Thapa, Dinesh ; Warne, Leon N ; Falasca, Marco</creatorcontrib><description>Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots, flowers, seeds, and leaves have been utilized to alleviate pain, inflammation, anxiety, and gastrointestinal disorders like nausea, vomiting, diarrhoea, and inflammatory bowel diseases (IBDs). It has occupied a significant space in ethnomedicines across cultures and religions. Despite multi-dimensional uses, the global prohibition of cannabis by the USA through the introduction of the Marijuana Tax Act in 1937 led to prejudice about the perceived risks of cannabis, overshadowing its medicinal potential. Nevertheless, the discovery of tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, and the endocannabinoid system renewed scientific interest in understanding the role of cannabis in modulating different conditions, including gastrointestinal disorders. Preparations combining cannabidiol and THC have shown promise in mitigating gut symptoms through anti-inflammatory and motility-enhancing effects. This review revisits the ethnomedicinal use of cannabis in gastrointestinal diseases and emphasizes the need for further research to determine optimal dosages, formulations, and safety profiles of cannabis-based medicines. It also underscores the future potential of cannabinoid-based therapies by leveraging the role of the expanded endocannabinoid system, an endocannabinoidome, in the modulation of gastrointestinal ailments.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms241914677</identifier><identifier>PMID: 37834122</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Bioavailability ; Cancer therapies ; Disease prevention ; Drug development ; Drug dosages ; Ethnomedicine ; Festivals ; Gastrointestinal diseases ; Hinduism ; Hindus ; Inflammation ; Influenza ; Marijuana ; Mediation ; Medical marijuana ; Nabilone ; Natural products ; Nausea ; Pain ; Patient compliance ; Pharmaceuticals ; Religion ; Review ; Tetrahydrocannabinol ; THC ; Vomiting</subject><ispartof>International journal of molecular sciences, 2023-10, Vol.24 (19), p.14677</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-3ef9b8bb52973eddde7ee09ad91823bfcc623748d1a2cd3eb7904de899c34da3</citedby><cites>FETCH-LOGICAL-c460t-3ef9b8bb52973eddde7ee09ad91823bfcc623748d1a2cd3eb7904de899c34da3</cites><orcidid>0000-0002-6369-0219 ; 0000-0002-9801-7235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572150/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572150/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Thapa, Dinesh</creatorcontrib><creatorcontrib>Warne, Leon N</creatorcontrib><creatorcontrib>Falasca, Marco</creatorcontrib><title>Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases</title><title>International journal of molecular sciences</title><description>Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots, flowers, seeds, and leaves have been utilized to alleviate pain, inflammation, anxiety, and gastrointestinal disorders like nausea, vomiting, diarrhoea, and inflammatory bowel diseases (IBDs). It has occupied a significant space in ethnomedicines across cultures and religions. Despite multi-dimensional uses, the global prohibition of cannabis by the USA through the introduction of the Marijuana Tax Act in 1937 led to prejudice about the perceived risks of cannabis, overshadowing its medicinal potential. Nevertheless, the discovery of tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, and the endocannabinoid system renewed scientific interest in understanding the role of cannabis in modulating different conditions, including gastrointestinal disorders. Preparations combining cannabidiol and THC have shown promise in mitigating gut symptoms through anti-inflammatory and motility-enhancing effects. This review revisits the ethnomedicinal use of cannabis in gastrointestinal diseases and emphasizes the need for further research to determine optimal dosages, formulations, and safety profiles of cannabis-based medicines. It also underscores the future potential of cannabinoid-based therapies by leveraging the role of the expanded endocannabinoid system, an endocannabinoidome, in the modulation of gastrointestinal ailments.</description><subject>Bioavailability</subject><subject>Cancer therapies</subject><subject>Disease prevention</subject><subject>Drug development</subject><subject>Drug dosages</subject><subject>Ethnomedicine</subject><subject>Festivals</subject><subject>Gastrointestinal diseases</subject><subject>Hinduism</subject><subject>Hindus</subject><subject>Inflammation</subject><subject>Influenza</subject><subject>Marijuana</subject><subject>Mediation</subject><subject>Medical marijuana</subject><subject>Nabilone</subject><subject>Natural products</subject><subject>Nausea</subject><subject>Pain</subject><subject>Patient compliance</subject><subject>Pharmaceuticals</subject><subject>Religion</subject><subject>Review</subject><subject>Tetrahydrocannabinol</subject><subject>THC</subject><subject>Vomiting</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptks9u1DAQxi0EoqVw5G6JC5cU_0ni-IRWu7QgVdBDOVuOPdn1yrEXOynaGw_BE_ZJ6qUVsAj5MJb9m2_m0wxCryk551ySd247ZlZTSetWiCfolNaMVYS04ulf9xP0IuctIYyzRj5HJ1x0vKaMnSJ_vdFp1CZuXJ5i2uM44KUOQfcu468Z7n78XODP8B1fx5xd77yb9tgFfDFPcwK8SvMar-AWfNyNECY8xIQvdZ5SdGGCPLmgPV65DDpDfomeDdpnePUYz9DNxYeb5cfq6svlp-XiqjJ1S6aKwyD7ru8bJgUHay0IACK1lbRjvB-MaRkXdWepZsZy6IUktYVOSsNrq_kZev8gu5v7EawpfSXt1S65Uae9itqp45_gNmodbxUljWC0IUXh7aNCit_mYkONLhvwXgeIc1asE4KXqrwr6Jt_0G2cU3H9i2oFL003f6i19qBcGGIpbA6iaiEE7UjXyIPW-X-ociyMzsQAgyvvRwnVQ4JJZTwJht8mKVGH9VBH68HvAUUMrpE</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Thapa, Dinesh</creator><creator>Warne, Leon N</creator><creator>Falasca, Marco</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6369-0219</orcidid><orcidid>https://orcid.org/0000-0002-9801-7235</orcidid></search><sort><creationdate>20231001</creationdate><title>Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases</title><author>Thapa, Dinesh ; Warne, Leon N ; Falasca, Marco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-3ef9b8bb52973eddde7ee09ad91823bfcc623748d1a2cd3eb7904de899c34da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bioavailability</topic><topic>Cancer therapies</topic><topic>Disease prevention</topic><topic>Drug development</topic><topic>Drug dosages</topic><topic>Ethnomedicine</topic><topic>Festivals</topic><topic>Gastrointestinal diseases</topic><topic>Hinduism</topic><topic>Hindus</topic><topic>Inflammation</topic><topic>Influenza</topic><topic>Marijuana</topic><topic>Mediation</topic><topic>Medical marijuana</topic><topic>Nabilone</topic><topic>Natural products</topic><topic>Nausea</topic><topic>Pain</topic><topic>Patient compliance</topic><topic>Pharmaceuticals</topic><topic>Religion</topic><topic>Review</topic><topic>Tetrahydrocannabinol</topic><topic>THC</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thapa, Dinesh</creatorcontrib><creatorcontrib>Warne, Leon N</creatorcontrib><creatorcontrib>Falasca, Marco</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thapa, Dinesh</au><au>Warne, Leon N</au><au>Falasca, Marco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases</atitle><jtitle>International journal of molecular sciences</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>24</volume><issue>19</issue><spage>14677</spage><pages>14677-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots, flowers, seeds, and leaves have been utilized to alleviate pain, inflammation, anxiety, and gastrointestinal disorders like nausea, vomiting, diarrhoea, and inflammatory bowel diseases (IBDs). It has occupied a significant space in ethnomedicines across cultures and religions. Despite multi-dimensional uses, the global prohibition of cannabis by the USA through the introduction of the Marijuana Tax Act in 1937 led to prejudice about the perceived risks of cannabis, overshadowing its medicinal potential. Nevertheless, the discovery of tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, and the endocannabinoid system renewed scientific interest in understanding the role of cannabis in modulating different conditions, including gastrointestinal disorders. Preparations combining cannabidiol and THC have shown promise in mitigating gut symptoms through anti-inflammatory and motility-enhancing effects. This review revisits the ethnomedicinal use of cannabis in gastrointestinal diseases and emphasizes the need for further research to determine optimal dosages, formulations, and safety profiles of cannabis-based medicines. It also underscores the future potential of cannabinoid-based therapies by leveraging the role of the expanded endocannabinoid system, an endocannabinoidome, in the modulation of gastrointestinal ailments.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37834122</pmid><doi>10.3390/ijms241914677</doi><orcidid>https://orcid.org/0000-0002-6369-0219</orcidid><orcidid>https://orcid.org/0000-0002-9801-7235</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2023-10, Vol.24 (19), p.14677 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10572150 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Bioavailability Cancer therapies Disease prevention Drug development Drug dosages Ethnomedicine Festivals Gastrointestinal diseases Hinduism Hindus Inflammation Influenza Marijuana Mediation Medical marijuana Nabilone Natural products Nausea Pain Patient compliance Pharmaceuticals Religion Review Tetrahydrocannabinol THC Vomiting |
| title | Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacohistory%20of%20Cannabis%20Use%E2%80%94A%20New%20Possibility%20in%20Future%20Drug%20Development%20for%20Gastrointestinal%20Diseases&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Thapa,%20Dinesh&rft.date=2023-10-01&rft.volume=24&rft.issue=19&rft.spage=14677&rft.pages=14677-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms241914677&rft_dat=%3Cgale_pubme%3EA771808598%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876739185&rft_id=info:pmid/37834122&rft_galeid=A771808598&rfr_iscdi=true |